• Sector: Healthcare
  • Geography: United States
  • Stage: Growth
  • Investment Year: 2015
  • Website Link

Vertice Pharma

Vertice Pharma is a specialty branded and generic pharmaceuticals platform focused on acquiring specialty pharmaceuticals companies and products to create a durable specialty pharmaceutical platform of scale. Vertice Pharma was formed in 2015 by Warburg Pincus and senior pharmaceutical executive Don DeGolyer, former COO of Endo International plc and CEO of North America for Sandoz International GmbH. In late 2015, Warburg Pincus helped Vertice Pharma acquire VistaPharm, Inc., a Tampa, Florida-based specialty generics manufacturer of liquid and unit dosage medications focused on the hospital channel. Vertice Pharma has global headquarters in the United Kingdom and United States headquarters in New Providence, New Jersey.